Skip to main content
Home
  • About
  • Home
  • Forum
  • Groups
    • Group details
    • Groups-Private
  • Maps
  • Links
  • FAQs
  • Resources
    • Resource items
    • Resource nodes
  • HIFI
  • Systems

User login

  • Create new account
  • Request new password
What is the weather on the sun

Search form

Language

English Arabic Danish Dutch Filipino Finnish French German Greek Haitian Creole Hebrew Hindi Indonesian Irish Italian Japanese Korean Persian Portuguese Russian Spanish Swedish Thai Turkish Ukrainian Vietnamese

Anonymous's groups in this site

User is not a member of any group.

Your groups across all your sites

User is not a member of any group.

Recent Content

New method can identify fake COVID-19 vaccines without opening the vaccine vial--research
5 years since COVID declared public health emergency in US, still killing thousands
Analysis: Trump's flurry of orders undermine global health efforts
US flu infections continue to climb, with more deaths among kids --CDC
Trump EPA Dismisses the Agency's Outside Science Advisers

Recent Comments

  • Nonprofit group says Trump's pause will be harmful to Americans  4 days 27 sec ago
  • The impact of Trump's move to quit WHO and on global health 1 week 3 days ago
  • Trump's Paris climate exit will hit harder than in 2017- experts 1 week 3 days ago
  • CDC warns of 'high' respiratory virus activity as cases increase 1 month 1 day ago

Who's online

There are currently 0 users online.

Facebook  Twitter  RSS

You are here

Home

Disease Prevention

U.S. sends experimental antibody, antiviral drug to Uganda to counter Ebola outbreak

Tue, 2022-10-18 18:38 — mike kraft
U.S. sends experimental antibody, antiviral drug to Uganda for Ebola outbreak The United States sent Gilead Sciences' remdesivir and Mapp Biopharmaceutical Inc's experimental Ebola antibody drug MBP134 to Uganda last week to help safeguard healthcare workers responding to an outbreak that has infected 60 people and killed 44, U.S.
Country / Region Tags: 
Africa
Global
United States
General Topic Tags: 
Disease
Disease Prevention
Health
Public Health
Research
Problem, Solution, SitRep, or ?: 
Situation Report
  • Read more about U.S. sends experimental antibody, antiviral drug to Uganda to counter Ebola outbreak
  • Twitter logo
  • Facebook logo
  • Log in or register to post comments

COVID subvariants: Descriptions and spread

Tue, 2022-10-18 18:28 — mike kraft
COVID subvariants: What to know and should you be concerned? Newer subvariants, related to the BA.4 and BA.5 omicron subvariants, are making up an increasing number of COVID cases in the U.S., but experts say not to panic. ABC News ABC News
Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Symptoms
Treatments
Contagion
Disease
Disease Prevention
Government
Health
Mutations
Pandemics
Public Health
Research
Problem, Solution, SitRep, or ?: 
Situation Report
  • Read more about COVID subvariants: Descriptions and spread
  • Twitter logo
  • Facebook logo
  • Log in or register to post comments

It's 'not helpful' to view pandemic through political lens: White House COVID coordinator Dr. Jha

Tue, 2022-10-18 11:25 — mike kraft
It's 'not helpful' to view pandemic through political lens: White House COVID coordinator The White House's COVID-19 Response Team Coordinator Dr. Ashish Jha reflects on how politics hampered the country's pandemic response. YahooNews

...

"It's going to be very hard to manage our health-care system if we don't make some important changes," Jha said.

Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Boosters
Treatments
Contagion
Demographics
Disease
Disease Prevention
Government
Medical Testing
Mutations
Pandemics
Policy
Public Attitudes
Public Health
Science
Vaccinations
Citizens
Problem, Solution, SitRep, or ?: 
Other
  • Read more about It's 'not helpful' to view pandemic through political lens: White House COVID coordinator Dr. Jha
  • Twitter logo
  • Facebook logo
  • Log in or register to post comments

An addiction drug, Naltrexone, shows promise in countering long COVID brain fog, fatigue

Tue, 2022-10-18 10:22 — mike kraft
Addiction drug shows promise lifting long COVID brain fog, fatigue Lauren Nichols, a 34-year-old logistics expert for the U.S. Department of Transportation in Boston, has been suffering from impaired thinking and focus, fatigue, seizures, headache and pain since her COVID-19 infection in the spring of 2020. Julie Steenhuysen Reuters

...

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Symptoms
Treatments
Disease
Disease Prevention
Government
Health
Pandemics
Public Health
Research
Problem, Solution, SitRep, or ?: 
Situation Report
  • Read more about An addiction drug, Naltrexone, shows promise in countering long COVID brain fog, fatigue
  • Twitter logo
  • Facebook logo
  • Log in or register to post comments

A variety of variants could fuel a winter COVID surge

Tue, 2022-10-18 09:47 — mike kraft
XBB, BQ.1.1, BA.2.75.2 — a variant swarm could fuel a winter surge Multiple versions of the omicron variant, including XBB and BQ.1.1, threaten to knock out treatments and challenge vaccines this winter. Carolyn Y. Johnson Washington Post
Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Contagion
Disease
Disease Prevention
Health
Mutations
Pandemics
Public Health
Research
Science
Adaptation
Problem, Solution, SitRep, or ?: 
Analysis
Problem
  • Read more about A variety of variants could fuel a winter COVID surge
  • Twitter logo
  • Facebook logo
  • Log in or register to post comments

Public Trust Crucial to Reponses to Health Crisis--study

Tue, 2022-10-18 09:29 — mike kraft
Public Trust Can Make or Break Government Response to Public Health Crisis Global Health NOW
Country / Region Tags: 
Africa
Global
United States
General Topic Tags: 
COVID-19
Disease
Disease Prevention
Government
Health
Medical Personnel
Pandemics
Policy
Public Attitudes
Public Health
Research
Social behavior
Vaccinations
Problem, Solution, SitRep, or ?: 
Analysis
  • Read more about Public Trust Crucial to Reponses to Health Crisis--study
  • Twitter logo
  • Facebook logo
  • Log in or register to post comments

Biden’administration unveils biodefense strategy that aims to combat future pandemics

Tue, 2022-10-18 09:12 — mike kraft
Biden’s biodefense strategy aims to combat future pandemics The White House on Tuesday released its national biodefense strategy, outlining President Biden’s plan to protect the U.S. from future pandemics and biological threats. The plan, which utilizes 20 … agangitano The Hill

...

The plan, which utilizes 20 federal agencies, aims to detect early warnings of pandemics and biological threats, prevent epidemics and biological incidents, and prepare to reduce the impacts of epidemics....

Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Contagion
Disease
Disease Prevention
Government
Health
Pandemics
Policy
Public Health
Research
Science
Problem, Solution, SitRep, or ?: 
Situation Report
  • Read more about Biden’administration unveils biodefense strategy that aims to combat future pandemics
  • Twitter logo
  • Facebook logo
  • Log in or register to post comments

Trump administration blocked CDC transit mask mandate--Congressional comittee

Mon, 2022-10-17 17:34 — mike kraft
Trump administration blocked CDC transit mask mandate, report shows Former President Donald Trump's administration at a crucial time in the COVID-19 pandemic in 2020 blocked the U.S. Centers for Disease Control and Prevention (CDC) from adopting a federal mandate requiring face masks on airline flights and other forms of transit, a congressional report released on Monday said. David Shepardson Reuters
Country / Region Tags: 
Global
United States
General Topic Tags: 
Travel
COVID-19
Treatments
Disease
Disease Prevention
Government
Health
Mandates
Masks
Pandemics
Policy
Politics
Public Health
Science
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report
  • Read more about Trump administration blocked CDC transit mask mandate--Congressional comittee
  • Twitter logo
  • Facebook logo
  • Log in or register to post comments

Moderna CEO predicts that not everyone will need an annual COVID booster

Mon, 2022-10-17 14:50 — mike kraft
Moderna CEO: Not everyone will need an annual COVID booster Moderna CEO says not everyone will need an annual COVID booster. YahooFinance
 

The COVID-19 booster market is starting to look more like an annual flu season than it did in the first two years of the pandemic.

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Boosters
Demographics
Disease
Disease Prevention
Health
Mutations
Pandemics
Public Health
Research
Science
Vaccinations
Problem, Solution, SitRep, or ?: 
Analysis
  • Read more about Moderna CEO predicts that not everyone will need an annual COVID booster
  • Twitter logo
  • Facebook logo
  • Log in or register to post comments

Ebola: Uganda locks down two districts, Indian company to produce an experimental vaccine for Uganda's outbreak

Mon, 2022-10-17 14:24 — mike kraft
Uganda locks down 2 districts in bid to stem spread of Ebola KAMPALA, Uganda (AP) — Ugandan authorities on Saturday imposed a travel lockdown on two Ebola-hit districts as part of efforts to stop the spread of the contagious disease. The measures announced by President Yoweri Museveni mean residents of the central Ugandan districts of Mubende and Kassanda can't travel into or out of those areas by private or public means. AP NEWS
Country / Region Tags: 
Africa
Global
India
General Topic Tags: 
Treatments
Contagion
Disease
Disease Prevention
Health
Public Health
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report
  • Read more about Ebola: Uganda locks down two districts, Indian company to produce an experimental vaccine for Uganda's outbreak
  • Twitter logo
  • Facebook logo
  • Log in or register to post comments

Pages

  • « first
  • ‹ previous
  • …
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • …
  • next ›
  • last »
Subscribe to Disease Prevention
©Copyright 2021, OVIAR Global Resilience Systems, Inc.
howdy folks
Page loaded in 0.695 seconds.